Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/11/2007 | US7306909 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
12/11/2007 | US7306908 Mutant Dna; transcription of genomes |
12/11/2007 | US7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
12/11/2007 | US7306906 Engineered templates and their use in single primer amplification |
12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
12/11/2007 | US7306901 Methods and means for assessing HIV envelope inhibitor therapy |
12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
12/11/2007 | US7306806 Recombinant P. falciparum merozoite protein-142 vaccine |
12/11/2007 | US7306805 Nontypeable Haemophilus influenzae virulence factors |
12/11/2007 | US7306804 HIV-specific T-cell induction |
12/11/2007 | US7306799 Use of fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
12/11/2007 | US7306795 PRO5774 antibodies |
12/11/2007 | US7306794 Methods and compositions for the treatment of defects in lipoprotein metabolism |
12/11/2007 | US7306793 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
12/11/2007 | CA2224426C Cis-9,10-octadecenoamidase |
12/11/2007 | CA2189675C Process for producing cis-3-hydroxy-l-proline |
12/11/2007 | CA2188463C Pharmaceutical compositions containing activated protein c-resistant factor v for the treatment of bleeding disorders |
12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
12/11/2007 | CA2073630C Method for synthesizing single-stranded stem-loop dnas, the products and uses therefor |
12/08/2007 | CA2587092A1 A method of expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof |
12/06/2007 | WO2007140451A1 Methods for making and using wheat plants with increased grain protein content |
12/06/2007 | WO2007140274A1 Plasmid dna preparations and methods for producing same |
12/06/2007 | WO2007140256A1 Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof |
12/06/2007 | WO2007140011A2 Erythroid progenitor cells and methods for producing parvovirus b19 therein |
12/06/2007 | WO2007139982A2 Methods and compositions for gene inactivation |
12/06/2007 | WO2007139943A2 Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders |
12/06/2007 | WO2007139935A1 Innate immune response inducer |
12/06/2007 | WO2007139898A2 Variant foki cleavage half-domains |
12/06/2007 | WO2007139870A1 Genetically encoded fluorescent coumarin amino acids |
12/06/2007 | WO2007139608A1 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
12/06/2007 | WO2007139397A1 Ob fold domains |
12/06/2007 | WO2007139385A1 Methods for modulating potato tuber cooking type and plant tissue texture |
12/06/2007 | WO2007139373A1 Identification of tumor suppressor genes in an acute myeloid leukaemia model |
12/06/2007 | WO2007139279A1 Sweetpotato expansin cdna and high-yield transgenic plants using the same |
12/06/2007 | WO2007139246A1 The recombinant primary-microrna molecule for rna interference |
12/06/2007 | WO2007139229A1 Light-inducible and rhythmically expressed genes and method for screening substances that affect an internal clock system |
12/06/2007 | WO2007139219A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the rcsa gene |
12/06/2007 | WO2007139190A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
12/06/2007 | WO2007139178A1 Therapeutic agent for alzheimer's disease |
12/06/2007 | WO2007139164A1 Humanized anti-human osteopontin antibody |
12/06/2007 | WO2007139100A1 Method of examining soil pollution and/or water pollution |
12/06/2007 | WO2007139089A1 Improved method of determining chemical |
12/06/2007 | WO2007139080A1 Continuous assay method for measuring receptor- and ion channel-mediated calcium response and subsequent gene expression |
12/06/2007 | WO2007139055A1 Method for production of optically active amine compound, recombinant vector, and transformant carrying the vector |
12/06/2007 | WO2007139037A1 Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information |
12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
12/06/2007 | WO2007138894A1 Hydroxylase gene and use thereof |
12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
12/06/2007 | WO2007138712A1 USE OF HISTONE CHAPERONE ACTIVITY OF AGROBACTERIUM 6b PROTEIN |
12/06/2007 | WO2007138691A1 Polycystic kidney disease-related gene and use thereof |
12/06/2007 | WO2007138455A2 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
12/06/2007 | WO2007138444A2 Genetic markers for high oleic acid content in plants |
12/06/2007 | WO2007138324A2 Materials and complexes for the delivery of biologically-active material to cells |
12/06/2007 | WO2007138261A2 Modified sugar nucleotide |
12/06/2007 | WO2007138253A1 Screening method |
12/06/2007 | WO2007138198A2 Method for the extraction of one or several proteins present in milk |
12/06/2007 | WO2007138193A1 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
12/06/2007 | WO2007138155A1 Improved expression of tuberculosis vaccine proteins in plants |
12/06/2007 | WO2007138104A1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy |
12/06/2007 | WO2007138070A2 Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same |
12/06/2007 | WO2007138049A2 Chloramphenicol resistance selection in bacillus licheniformis |
12/06/2007 | WO2007138043A2 Sirna kinase and methods of use |
12/06/2007 | WO2007137973A2 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp) |
12/06/2007 | WO2007137810A1 Cytokinin receptor variants and their use |
12/06/2007 | WO2007137788A1 Plant virus-based inducible expression system |
12/06/2007 | WO2007137701A1 Mutated dna polymerase with increased reverse transcriptase activity |
12/06/2007 | WO2007137679A2 Device and substance for isolating mesenchymal stem cells (msc) |
12/06/2007 | WO2007137616A1 Highly diversified antibody libraries |
12/06/2007 | WO2007137586A2 Random insertion of peptides |
12/06/2007 | WO2007137456A1 A peptide for preventing or treating liver damage and its derivant and the use |
12/06/2007 | WO2007137361A1 Transcription regulators for reproduction associated plant part tissue specific expression |
12/06/2007 | WO2007137345A1 PLANT NUCLEIC ACIDS ASSOCIATED WITH CELLULAR pH AND USES THEREOF |
12/06/2007 | WO2007137342A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
12/06/2007 | WO2007117852A3 Targeted deletions using retroelement-mediated placement of recombination sites |
12/06/2007 | WO2007116394A3 Plant gene promoter and its use |
12/06/2007 | WO2007112953A8 Process for the purification of recombinant alpha 1-antitrypsin involving a step of anion exchange chromatography |
12/06/2007 | WO2007098257A3 Hiv tev compositions and methods of use |
12/06/2007 | WO2007095152A3 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
12/06/2007 | WO2007094983A3 Methods and compositions for the inhibition of hiv infection of t cells |
12/06/2007 | WO2007093776A3 Nucleic acid |
12/06/2007 | WO2007089375A3 Compositions and methods for regulating complement system |
12/06/2007 | WO2007080174A3 Chimeric and humanised anti-human il-13 antibodies |
12/06/2007 | WO2007079353A3 Increased seed size and seed number through transgenic over expression of a growth and/or development related gene during early embryo development |
12/06/2007 | WO2007072056A3 Vectors |
12/06/2007 | WO2007062245A3 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
12/06/2007 | WO2007055704A3 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
12/06/2007 | WO2007047791A3 Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
12/06/2007 | WO2007045903A3 Methods of analysing cell behaviour |
12/06/2007 | WO2007032792A3 Genetically modified yeast of the species issatchenkia orientalis and closely related species and fermentation processes using same |
12/06/2007 | WO2007014077A3 Rnai modulation of the rho-a gene and uses thereof |
12/06/2007 | WO2007005882A3 Methods and compositions for expressing proteins in plants |
12/06/2007 | WO2007003346A3 Fungicidal agents |
12/06/2007 | WO2006130470A3 Methods and compositions comprising chimeric and full-length human acetyl-coa carboxylase |
12/06/2007 | WO2006118547A8 Hyperbranched polymers and their applications |
12/06/2007 | WO2006037126A3 Method of treating an inflammatory disease by double stranded ribonucleic acid |
12/06/2007 | WO2006034332A3 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
12/06/2007 | WO2005118861A3 Compositions and methods for producing libraries with controlled compositions and screening probabilites |
12/06/2007 | WO2005072254A3 Modulation of sulfate permease for photosynthetic hydrogen production |